These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7304799)

  • 1. Dopamine beta-hydroxylase inhibition in a patient with Wilson's disease and manic symptoms.
    Pandey RS; Sreenivas KN; Patil NM; Swamy HS
    Am J Psychiatry; 1981 Dec; 138(12):1628-9. PubMed ID: 7304799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral effects of a new dopamine-beta-hydroxylase inhibitor (fusaric acid) in man.
    Goodwin FK; Sack RL
    J Psychiatr Res; 1974; 11():211-7. PubMed ID: 4618285
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of dopamine-b-hydroxylase in manic patients. A clinical trial and fusaric acid.
    Sack RL; Goodwin FK
    Arch Gen Psychiatry; 1974 Nov; 31(5):649-54. PubMed ID: 4613319
    [No Abstract]   [Full Text] [Related]  

  • 4. [Activity of the enzymes participating in the metabolism of biogenic amines in patients with depressive syndromes. III. Dopamine beta-hydroxylase (DBH) activity in the serum].
    Matsumoto H; Pacyna M; Pietruszewska I; Lewicka-Wysocka H
    Psychiatr Pol; 1983; 17(1):19-23. PubMed ID: 6622589
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum DBH and platelet MAO in patients with depressive disorders.
    Honecker H; Fähndrich E; Coper H; Helmchen H
    Pharmacopsychiatria; 1981 Jan; 14(1 Suppl):10-4. PubMed ID: 7248043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fusaric acid (a dopamine beta-hydroxylase inhibitor) on phaeochromocytoma.
    Nagasaka A; Hara I; Imai Y; Uchikawa T; Yamauchi K; Suzuki S; Takatsuki K; Tomita A; Niinomi M; Nakagawa H
    Clin Endocrinol (Oxf); 1985 Apr; 22(4):437-44. PubMed ID: 3987067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mania as the first manifestation of Wilson's disease.
    Machado AC; Deguti MM; Caixeta L; Spitz M; Lucato LT; Barbosa ER
    Bipolar Disord; 2008 May; 10(3):447-50. PubMed ID: 18402634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NIH conference. Dopamine- -hydroxylase. Basic and clinical studies.
    Kopin IJ; Kaufman S; Viveros H; Jacobowitz D; Lake CR; Ziegler MG; Lovenberg W; Goodwin FK
    Ann Intern Med; 1976 Aug; 85(2):211-23. PubMed ID: 782312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium treatment of a bipolar patient with Wilson's disease: a case report.
    Rybakowski JK; Litwin T; Chlopocka-Wozniak M; Czlonkowska A
    Pharmacopsychiatry; 2013 May; 46(3):120-1. PubMed ID: 23037949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The psychological effects of dopamine-beta-hydroxylase inhibition in normal subjects.
    Hartmann E; Keller-Teschke M
    Biol Psychiatry; 1979 Jun; 14(3):455-62. PubMed ID: 476231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum dopamine-beta-hydroxylase activity in female manic-depressive patients.
    Rihmer Z; Bagdy G; Arató M
    Biol Psychiatry; 1984 Mar; 19(3):423-7. PubMed ID: 6722232
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychological effects of dopamine beta-hydroxylase inhibition: a failure to replicate.
    Hartmann E; Oldfield M; Adelman S; Edelberg R
    Psychopharmacology (Berl); 1983; 79(4):352-6. PubMed ID: 6407052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum dopamine-beta-hydroxylase in manic-depressive psychosis.
    Ikeda Y; Ijima M; Nomura S
    Br J Psychiatry; 1982 Feb; 140():209-10. PubMed ID: 7074308
    [No Abstract]   [Full Text] [Related]  

  • 14. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The preliminary study of monoamine oxidase activity in platelets in patients with schizophrenia and affective disorder].
    Lin Y
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Dec; 25(6):325-7, 382. PubMed ID: 1304991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dopamine-beta-hydroxylase inhibitors on blood pressure and cardiac norepinephrine levels in rats subjected to immobilization stress.
    Ishii Y; Mimura C; Homma M
    J Pharmacol Exp Ther; 1976 Sep; 198(3):589-95. PubMed ID: 988175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine-beta-hydroxylase: evidence for increased activity in sympathetic neurons during psychotic states.
    Rosenblatt S; Leighton WP; Chanley JD
    Science; 1973 Nov; 182(4115):923-4. PubMed ID: 4745595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dopamine-beta-hydroxylase inhibition on cerebral vasospasm in the cat.
    Battista AF; Flamm ES; Goldstein M; Freedman LS
    J Neurosurg; 1976 Feb; 44(2):168-72. PubMed ID: 1245859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control experiment in man on the sedative effect of disulfiram, an inhibitor of dopamine-beta-hydroxylase.
    Auriol B; Bardou E; Lambic C
    Biol Psychiatry; 1980 Aug; 15(4):623-5. PubMed ID: 7397293
    [No Abstract]   [Full Text] [Related]  

  • 20. Biology of schizophrenia: Mental effects of dopamine-beta-hydroxylase inhibition in normal men.
    Hartmann E; Keller-Teschke M
    Lancet; 1977 Jan; 1(8001):37-8. PubMed ID: 63668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.